Treasury shares and authorisations



Caverion Corporation currently holds 512,328 treasury shares.

 

Date

Change, number

Own shares, total

Incident

 April 1, 2016 237   512,328 Caverion Corporation received 237 own shares according to the terms and conditions of share-based incentive scheme.*) 
 December 31, 2015 630   512,091 Caverion Corporation received 630 own shares according to the terms and conditions of share-based incentive scheme.*)

 October 1, 2015  474  511,461 Caverion Corporation received 474 own shares according to the terms and conditions of share-based incentive scheme.*)

March 12, 2015

1,493

510,750
 
Caverion Corporation received 1,493 own shares according to the terms and conditions of share-based incentive scheme.*)

December 31, 2014 2,102  509,257 
Caverion Corporation received 2,102 own shares according to the terms and conditions of share-based incentive scheme. *)


September 30, 2014

1,518 

507,155

Caverion Corporation received 1,518 own shares according to the terms and conditions of share-based incentive scheme. *)

July 23, 2014−August 12, 2014  500,000  505,637

Caverion Corporation repurchased 500,000 own shares based on the authorization given by the Annual General Meeting on March 17, 2014. The shares were purchased to accomplish and hedge the long-term share-based incentive plan 2014−2016 for the company’s key senior executives.

The shares were acquired in a public trading arranged by NASDAQ OMX Helsinki Ltd at the market price on July 23, 2014− August 12, 2014.

Cumulative turnover was EUR 3,172,965.90 and cumulative price EUR  6.3459. 

March 13, 2014
 
1,557

5,637

Caverion Corporation received 1,557 own shares according to the terms and conditions of share-based incentive scheme. *)

Dec 31, 2013
 
2,706
 
4,080
 

Caverion Corporation received 2,706 own shares according to the terms and conditions of share-based incentive scheme. *)


Sep 30, 2013

1,374

1,374

Caverion Corporation received 1,374 own shares according to the terms and conditions of share-based incentive scheme. *)

*) The shares were initially transferred to those key persons who were included in the target group of YIT Corporation’s share-based incentive scheme of 2010−2016 during the 2011−2012 earnings periods, and who have later in the demerger of YIT Corporation transferred to Caverion Corporation’s employ.

Authorisations of the Board of Directors

 Annual General Meeting 2017

The Annual General Meeting of Caverion Corporation, held on March 17, 2017, authorised Caverion’s Board of Directors to decide on the repurchase of own shares. 

The authorisation covers the repurchase of a maximum of 12,000,000 company’s own shares using the company’s unrestricted equity, at fair value at the date of repurchase, which shall be the prevailing market price in the trading at the regulated market organised by Nasdaq Helsinki Ltd. The shares may be repurchased other than pro rata to the shareholders’ existing holdings. The share purchase will decrease the company’s distributable unrestricted equity. 

The authorisation is valid for eighteen months from the date of the resolution of the Annual General Meeting. The previous authority granted by the Annual General Meeting of March 21, 2016 simultaneously expired. The Board of Directors has not used the authorisation during 2017.

Annual General Meeting 2016

The Annual General Meeting of Caverion Corporation, held on March 21, 2016, authorised Caverion’s Board of Directors to decide on the repurchase of own shares.

The authorisation covers the repurchase of a maximum of 12,000,000 company´s own shares using the company's unrestricted equity, at fair value at the date of repurchase, which shall be the prevailing market price in the trading at the regulated market organized by Nasdaq Helsinki Ltd. The shares may be repurchased other than pro rata to the shareholders’ existing holdings.

The authorisation is valid for eighteen months from the date of the resolution of the Annual General Meeting. The Board of Directors did not used the authorisation during 2016.

Annual General Meeting 2015

The Annual General Meeting held on March 16, 2015 authorised Caverion’s Board of Directors to decide on the repurchase of own shares as follows:

  • The authorisation covers the purchasing of a maximum of 12,000,000 company shares using the funds from the company's unrestricted equity.
  • The shares may be repurchased other than pro rata to the shareholders’ existing holdings.
  • The shares will be purchased at the regulated market organized by NASDAQ OMX Helsinki Ltd.
  • The authorisation is valid for eighteen months from the date of the resolution of the Annual General Meeting.


Annual General Meeting 2014

The Annual General Meeting of Caverion Corporation, held on March 17, 2014, authorised Caverion’s Board of Directors to decide on the repurchase of own shares using the Company’s unrestricted equity under the following terms and conditions;

  • The authorisation covers the purchasing of a maximum of 12,500,000 company shares using the funds from the company's unrestricted equity.
  • The shares are not to be purchased in proportion to the shareholders’ holdings. The shares will be purchased in public trading on NASDAQ OMX Helsinki Ltd.
  • The authorisation is valid until March 31, 2015.
The Board of Directors resolved on July 21, 2014 to start a share repurchase program based on the authorisation given by the Annual General Meeting of Shareholders. The Board of Directors resolved to acquire a maximum of 500,000 company's own shares, which were all acquired in public trading arranged by NASDAQ OMX Helsinki Ltd during July 23 – August 12.